Tarsons Products Limited (NSE:TARSONS)
India · Delayed Price · Currency is INR 298.50
+0.50 (0.17%)
Oct 13, 2025, 3:29 PM IST
Tarsons Products Revenue
Tarsons Products had revenue of 913.64M INR in the quarter ending June 30, 2025, with 7.74% growth. This brings the company's revenue in the last twelve months to 3.99B, up 25.22% year-over-year. In the fiscal year ending March 31, 2025, Tarsons Products had annual revenue of 3.92B with 32.40% growth.
Revenue (ttm)
3.99B
Revenue Growth
+25.22%
P/S Ratio
3.97
Revenue / Employee
4.40M
Employees
906
Market Cap
15.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.92B | 960.20M | 32.40% |
| Mar 31, 2024 | 2.96B | 131.46M | 4.64% |
| Mar 31, 2023 | 2.83B | -175.46M | -5.83% |
| Mar 31, 2022 | 3.01B | 694.77M | 30.04% |
| Mar 31, 2021 | 2.31B | 563.32M | 32.19% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Divi's Laboratories | 96.52B |
| Cipla | 274.80B |
| Apollo Hospitals Enterprise | 225.51B |
| Mankind Pharma | 129.10B |
| Zydus Lifesciences | 236.08B |
| Fortis Healthcare | 80.94B |
| Alkem Laboratories | 133.04B |